Closely-held Contextual Genomics has teamed up with CORE Diagnostics to introduce its Find-It genomic test in India.Read More
Microbix Biosystems (TSX:MBX) has signed a distribution agreement with Meridian Life Science, a wholly owned unit of Meridian Bioscience (NASDAQ:VIVO), a fully integrated global diagnostic and life sciences company.Read More
Venaxis (NASDAQ:APPY), closely-held Strand Life Sciences of India and its U.S. subsidiary, Strand Genomics, have terminated a series of transactions between the companies.
The termination affects an asset purchase agreement between Venaxis and Strand Genomics, and share sale agreements and investment agreements between Venaxis and Strand Life shareholders.Read More
Venaxis (NASDAQ:APPY) has entered into a series of agreements for a transaction with Strand Life Sciences Private Limited and its shareholders. Strand is a privately-held, global genomics and bioinformatics company based in India.
The effect of the transaction will be that Strand shareholders and the employees and directors who are option-holders in Strand will own directly and beneficially approximately 68% of the combined enterprise and the current shareholders of Venaxis will own approximately 32%.Read More